Van Berkom & Associates Inc. Charles River Laboratories International, Inc. Transaction History

Van Berkom & Associates Inc.

$3.65 Billion
Q3 2024

A detailed history of Van Berkom & Associates Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Van Berkom & Associates Inc. holds 389,834 shares of CRL stock, worth $73.2 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

389,834

Previous 318,228 22.5%

Holding current value

$73.2 Million

Previous $65.7 Million 16.8%

% of portfolio

2.11%

Previous 1.96%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$187.96 - $245.29 $13.5 Million - $17.6 Million	71,606 Added 22.5%	389,834 $76.8 Million
Q2 2024 Aug 07, 2024	BUY	$206.39 - $268.73 $1.4 Million - $1.82 Million	6,762 Added 2.17%	318,228 $65.7 Million
Q1 2024 May 13, 2024	SELL	$203.52 - $273.43 $1.41 Million - $1.9 Million	-6,947 Reduced 2.18%	311,466 $84.4 Million
Q4 2023 Feb 06, 2024	BUY	$164.52 - $238.84 $15.8 Million - $23 Million	96,215 Added 43.3%	318,413 $75.3 Million
Q3 2023 Nov 07, 2023	BUY	$194.44 - $217.61 $6.53 Million - $7.31 Million	33,570 Added 17.8%	222,198 $43.5 Million
Q2 2023 Aug 07, 2023	SELL	$183.71 - $210.25 $436,678 - $499,764	-2,377 Reduced 1.24%	188,628 $39.7 Million
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $2.1 Million - $2.85 Million	10,955 Added 6.08%	191,005 $38.5 Million
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $1,773 - $2,250	9 Added 0.0%	180,050 $39.2 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $3.45 Million - $4.74 Million	-18,905 Reduced 9.5%	180,041 $35.4 Million
Q2 2022 Jul 22, 2022	SELL	$204.13 - $302.4 $494,198 - $732,110	-2,421 Reduced 1.2%	198,946 $42.6 Million
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $5.25 Million - $7.44 Million	-20,553 Reduced 9.26%	201,367 $57.2 Million
Q4 2021 Feb 02, 2022	SELL	$351.38 - $448.68 $2.03 Million - $2.59 Million	-5,765 Reduced 2.53%	221,920 $83.6 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $42.7 Million - $52.5 Million	-114,641 Reduced 33.49%	227,685 $94 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $48.3 Million - $61.1 Million	-164,338 Reduced 32.44%	342,326 $127 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $8.35 Million - $10 Million	-33,463 Reduced 6.2%	506,664 $147 Million
Q4 2020 Feb 05, 2021	SELL	$222.0 - $252.62 $807,414 - $918,778	-3,637 Reduced 0.67%	540,127 $135 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $21.1 Million - $27.2 Million	-120,091 Reduced 18.09%	543,764 $123 Million
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $4.75 Million - $7.58 Million	-39,945 Reduced 5.68%	663,855 $116 Million
Q1 2020 May 26, 2020	BUY	$98.9 - $178.34 $11.9 Million - $21.4 Million	119,919 Added 20.54%	703,800 $88.8 Million
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $118,360 - $143,441	939 Added 0.16%	583,881 $89.2 Million
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $1.08 Million - $1.24 Million	8,665 Added 1.51%	582,942 $77.2 Million
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $184,483 - $222,082	-1,495 Reduced 0.26%	574,277 $81.5 Million
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $867,804 - $1.21 Million	-8,279 Reduced 1.42%	575,772 $83.6 Million
Q4 2018 Feb 13, 2019	SELL	$105.09 - $137.23 $2.12 Million - $2.77 Million	-20,204 Reduced 3.34%	584,051 $66.1 Million
Q3 2018 Nov 08, 2018	SELL	$112.11 - $134.54 $1.47 Million - $1.77 Million	-13,136 Reduced 2.13%	604,255 $81.3 Million
Q2 2018 Aug 09, 2018	BUY	$102.37 - $117.25 $435,072 - $498,312	4,250 Added 0.69%	617,391 $69.3 Million
Q1 2018 May 08, 2018	BUY	$98.19 - $115.2 $2.31 Million - $2.71 Million	23,504 Added 3.99%	613,141 $65.4 Million
Q4 2017 Feb 13, 2018	SELL	$100.43 - $118.09 $6.25 Million - $7.35 Million	-62,216 Reduced 9.54%	589,637 $64.5 Million
Q3 2017 Nov 09, 2017	BUY	$96.72 - $109.26 $63 Million - $71.2 Million	651,853	651,853 $70.4 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Berkom & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Berkom & Associates Inc. with notifications on news.

Account

Van Berkom & Associates Inc. Charles River Laboratories International, Inc. Transaction History